Drugs News and Research

RSS

Life Technologies introduces CytoTune-iPS Reprogramming Kit

Life Technologies Corporation today announced the launch of CytoTune-iPS Reprogramming Kit -- research technology that provides far improved efficiency over standard methods to develop induced pluripotent stem cells from human somatic cells.

16 Jun 2011

Scientists discover new cell type in the immune system

A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.

16 Jun 2011

Brain research funds crisis: Report

According to the European College of Neuropsychopharmacology there is a dramatic drop in private and public funding for research in brain diseases that has led to a “withdrawal of hope” for millions of sufferers and could delay the search for treatments and cures by 30 years.

16 Jun 2011

Cholesterol-lowering statins reduce rate of mortality and cardiovascular events

Over the long term, treatment with cholesterol-lowering statins reduces the rate of mortality and cardiovascular events such as heart attack, for people with and without heart disease. Still, it is unclear whether these drugs take effect rapidly when the risk of these dire events is highest.

15 Jun 2011

NIH awards $20 million research grant to University of Kentucky

The National Institutes of Health (NIH), the largest government funding source for biomedical research in the United States, has awarded $20 million to the University of Kentucky to move research discoveries to health care solutions more quickly.

15 Jun 2011

Pharma IQ launches Global HTA and CER Forum

Pharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course of August.

15 Jun 2011

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.

15 Jun 2011

Russian CRO market expects to report yearly growth of 9.5% between 2009 and 2017

The Russian CRO market is set to emerge as a distinct competitor in the global CRO market, expected to report yearly growth of 9.5% between 2009 and 2017, according to a new report on companiesandmarkets.com.

15 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

University of British Columbia researchers - using an innovative, atom-by-atom substitution method - have uncovered the mechanism by which a particular class of drugs controls irregular heartbeats.

15 Jun 2011

Copper induces protein misfolding, creates fibrillar plaques of Parkinson's disease

Researchers at North Carolina State University have figured out how copper induces misfolding in the protein associated with Parkinson's disease, leading to creation of the fibrillar plaques which characterize the disease.

15 Jun 2011

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

CONRAD and the South African Government's Technology Innovation Agency (TIA) today announced a license agreement that grants TIA the rights to manufacture and distribute Tenofovir1% gel in Africa.

15 Jun 2011

PDR launches new online network to collect, distribute adverse drug events in the U.S.

PDR Network and its partners today announced the launch of a new online network to collect and distribute adverse drug events in the United States.

From Physicians' Desk Reference (PDR) 15 Jun 2011

Congress cuts critical funding for prostate cancer research

Congress is poised to ruin Father's Day for millions of men and their families by drastically cutting funding for prostate cancer research. Today, the House Appropriations Committee approved a bill that would provide $64 million in FY2012 for the Prostate Cancer Research Program as part of the Department of Defense's Congressionally Directed Medical Research Program.

15 Jun 2011

Roundup: Conn.'s 'moderate' Medicaid cuts; Calif. adult day care threatened; disabled face 'unclear futures'

The national Center for Reproductive Rights filed a federal lawsuit Monday to halt implementation of the requirements that women wanting an abortion must have a sonogram and hear a detailed description of the fetus. The group called the mandates patronizing and an intrusion into the doctor-patient relationship.

15 Jun 2011

Boiron launches new natural and non-steroidal products for athletes to treat muscle pain

Boiron Canada launches Arnicare Sport, a brand new product designed for athletes, whether professional, amateur or recreational. Arnicare Sport makes physical activity pleasant by preventing and reducing cramps, aches and muscular fatigue.

14 Jun 2011

CerebralRx launches FitNeS vagus nerve stimulation system for treating epilepsy

CerebralRx, a newly formed spin-off of implantable neuromodulation systems developer BioControl Medical, has announced market entry with the launch of its FitNeS vagus nerve stimulation system.

14 Jun 2011

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.

14 Jun 2011

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers filed a lawsuit against Abbott Laboratories in federal court today claiming Abbott's blockbuster drug, Humira, caused a fungal infection resulting in the near-death of a Tennessee man.

14 Jun 2011

TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes

TWi Biotechnology Inc. announced today that the company has enrolled over 50% of the total 240 patients for the Phase IIb clinical trial of AC-201 for the treatment of Type II Diabetes.

14 Jun 2011

Drugs News and Research

Life Technologies introduces CytoTune-iPS Reprogramming Kit

Scientists discover new cell type in the immune system

Brain research funds crisis: Report

Cholesterol-lowering statins reduce rate of mortality and cardiovascular events

NIH awards $20 million research grant to University of Kentucky

Pharma IQ launches Global HTA and CER Forum

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Russian CRO market expects to report yearly growth of 9.5% between 2009 and 2017

ESC publishes position paper to raise the profile of vulnerable plaques

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

Copper induces protein misfolding, creates fibrillar plaques of Parkinson's disease

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

PDR launches new online network to collect, distribute adverse drug events in the U.S.

Congress cuts critical funding for prostate cancer research

Roundup: Conn.'s 'moderate' Medicaid cuts; Calif. adult day care threatened; disabled face 'unclear futures'

Boiron launches new natural and non-steroidal products for athletes to treat muscle pain

CerebralRx launches FitNeS vagus nerve stimulation system for treating epilepsy

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

Humira defect lawyers file suit against Abbott Laboratories in federal court

TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News